GENE ONLINE|News &
Opinion
Blog

Roche
What to Expect from the ASCO20 Virtual Program
2020-05-29
Vividion Inks $135 Million Deal with Roche for Targeted Protein Degraders
2020-05-20
Roche’s Tecentriq Bags Landmark FDA Approval as First-Line Monotherapy for Metastatic NSCLC
2020-05-20
New Antigen and Antibody-Based Kits Bolster Coronavirus Fight
2020-05-03
Potential Repurposed Drugs Currently in Evaluation for COVID-19
2020-05-01
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
Arrakis Signs Lucrative Deal with Roche to Develop RNA Targeting Small Molecules
2020-04-09
Roche Identifies Biomarker that Determines Patient Response to Immunotherapy
2020-03-15
Thermo Fisher’s Coronavirus Detection Kit Gets FDA Emergency Authorization
2020-03-14
Roche Gets Emergency FDA Approval for Fastest COVID-19 Diagnostic Test Yet
2020-03-13
Roche’s Elecsys GALAD Score that Predicts HCC Occurrence, Bags Breakthrough Designation
2020-03-06
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
R&D
Polivy – A New and Improved Arsenal from Roche to Fight DLBCL Relapse
2020-01-24
GeneOnline’s Top Mergers and Acquisitions of 2019
2019-12-31
1 3 4 5 6
LATEST
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
AstraZeneca’s Latest Moves in Pharmaceuticals in Q1 2024
2024-03-21
AI-Designed Antibodies: A Revolution in Antibody Drug Discovery
2024-03-20
Orchard Therapeutics’ Gene Therapy for Rare Neurological Disorder Wins FDA Approval
2024-03-20
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top